36 reports

Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.

  • Medical Biotechnology
  • Therapy
  • Switzerland
  • Forecast
  • Market Size
  • the Increasing Popularity of Natural Remedies Also Leads To Declines

This changed on ## January 2019 and is now as follows: A - no changes, B - only available through pharmacies and prescription is required, except a) medications previously classified as cat C medications - these can be provided without a prescription, b) medications for the

  • Analgesic
  • OTC
  • Therapy
  • Switzerland
  • Demand
  • Jun 13, 2016: Addex mGluR4 Program Demonstrates Potential in Preclinical Models of Neurodegenerative and Psychiatric Diseases
  • Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Product Development Milestones

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Psychotic Disorder
  • Therapy
  • Switzerland
  • Product Initiative
  • Addex Therapeutics Ltd
  • Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Product Development Milestones
  • Jun 13, 2016: Addex mGluR4 Program Demonstrates Potential in Preclinical Models of Neurodegenerative and Psychiatric Diseases

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Psychotic Disorder
  • Therapy
  • Switzerland
  • Product Initiative
  • Addex Therapeutics Ltd
  • NBE Therapeutics Enters into Co-Development Agreement with SOTIO
  • VENTURE FINANCING

The company intends to use the proceeds to advance the program NBE-## targeting ROR-## primarily for the treatment of solid tumors into clinical development and additional ADC pipeline programs through early development.

  • Therapy
  • Canada
  • Switzerland
  • United States
  • Company

Clevegen targets a cell surface receptor called Clever-##.

  • Cell Therapy
  • Therapy
  • Switzerland
  • Company
  • Selexis SA
  • OTHER SIGNIFICANT DEVELOPMENTS
  • EQUITY OFFERING

Its pipeline portfolio includes targeted liposomal doxorubicin TLD-##/ Talidox for the treatment of advanced metastatic tumors.

  • Pharmaceutical
  • Therapy
  • Switzerland
  • Deals & Alliance
  • NOVIMMUNE SA, DEALS BY THERAPY AREA, 2012 TO YTD 2018
  • PARTNERSHIPS

The additional unpaid payments may, however, be accelerated by either party at any time after ## July 2019.

  • Pharmaceutical
  • Therapy
  • Switzerland
  • Company
  • Novimmune SA
  • EXPERIMENTAL THERAPEUTICS AND DEBIOPHARM ENTER INTO AGREEMENT TO DEVELOP EPIGENETIC ONCOLOGY TARGET
  • DEBIOPHARM GROUP ACQUIRES ANTIBIOTIC CLINICAL ASSETS AND TECHNOLOGY PLATFORM FROM AFFINIUM

Almac Discovery' s pipeline products include ALM##, a microtubule binding agent in Phase ## for the treatment of solid tumours; ALM##, a allosteric Akt inhibitor; and Wee-## Inhibitor for the control of cell cycle.

  • Pharmaceutical
  • Therapy
  • Switzerland
  • Company
  • Debiopharm Group
  • Jun 13, 2016: Addex mGluR4 Program Demonstrates Potential in Preclinical Models of Neurodegenerative and Psychiatric Diseases
  • Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Product Development Milestones

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Psychotic Disorder
  • Therapy
  • Switzerland
  • Product Initiative
  • Addex Therapeutics Ltd
  • ALS TDI and Anelixis Therapeutics Enters into Research Agreement with Neurimmune
  • Neurimmune Therapeutics Enters into Co-Development Agreement with Ono Pharma

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Pharmaceutical
  • Therapy
  • Switzerland
  • Company
  • Neurimmune
  • Sanofi-Aventis Extends Agreement with Medicines For Malaria Venture
  • Merck Serono Enters into Co-Development Agreement with MMV

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Malaria
  • Therapy
  • Switzerland
  • Company Operations
  • Eisai Co., Ltd.
  • Sep 06, 2018: Polyphor reports financial results for the first half 2018

GlobalData Region Europe Asia-Pacific North America Middle East and Africa South and Central America No. of Deals ## ## ## NA NA Deal Value (US$ million) ##. ## NA NA NA NA Polyphor AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Polyphor AG, Pha

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Switzerland
  • Polyphor Ltd.
  • Prexton Therapeutics SA, Key Competitors
  • Domain Therapeutics Enters Into Option For Licensing Agreement With Prexton Therapeutics

GlobalData Prexton Therapeutics SA' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Therapy
  • Switzerland
  • Deals & Alliance
  • Prexton Therapeutics SA
  • LICENSING AGREEMENTS
  • VENTURE FINANCING

GlobalData PIQUR Therapeutics AG, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Therapy
  • Switzerland
  • Company
  • PIQUR Therapeutics AG
  • Sep 06, 2018: Polyphor reports financial results for the first half 2018

GlobalData Region Europe Asia-Pacific North America Middle East and Africa South and Central America No. of Deals ## ## ## NA NA Deal Value (US$ million) ##. ## NA NA NA NA Polyphor AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Polyphor AG, Pha

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Switzerland
  • Polyphor Ltd.
  • LICENSING AGREEMENTS
  • PARTNERSHIPS

He is one of the founders of the Company and has shepherded the organization through some very difficult times.

  • Therapy
  • Switzerland
  • Company
  • Virometix Raises Funds through Venture Financing
  • Virometix Raises Additional Funds through Venture Financing

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Therapy
  • Switzerland
  • Corporate Finance
  • Deals & Alliance
  • Virometix
  • Addex Therapeutics Plans To Enter Into Co-Development Agreement For Dipraglurant
  • Addex Therapeutics Enters into Partnership with National Institute on Alcohol Abuse and Alcoholism

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • Switzerland
  • Addex Therapeutics Ltd
  • LICENSING AGREEMENTS

GlobalData Therapy Area Central Nervous System Gastrointestinal Hematological Disorders Immunology Oncology No. of Deals ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA Ewopharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Switzerland
  • Deals & Alliance
  • VENTURE FINANCING

BioVersys provides one of its most innovative targets focused on gram-negative pathogens into this partnership.

  • Pharmaceutical
  • Therapy
  • Switzerland
  • Deals & Alliance
  • Bioversys
  • PARTNERSHIPS

GlobalData Region Europe Asia-Pacific North America Middle East and Africa South and Central America No. of Deals ## ## ## NA NA Deal Value (US$ million) NA NA NA NA NA OGD## Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 OGD## Pharma SAS,

  • Healthcare
  • Medical Biotechnology
  • Therapy
  • Switzerland
  • Deals & Alliance
  • Apr 03, 2018: Scripps Research discovery paves way for better flu prevention, treatment
  • MIRNA THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH UNIVERSITY OF ZURICH

" We have found one candidate.

  • Therapy
  • Switzerland
  • Company
  • Deals & Alliance
  • Viventia Bio Inc.

GlobalData Region Europe North America Asia-Pacific Middle East and Africa South and Central America No. of Deals ## ## NA NA NA Deal Value (US$ million) NA NA NA NA NA Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Redbiotec AG, Pharmaceuticals &

  • Pharmaceutical
  • Therapy
  • Switzerland
  • Deals & Alliance
  • Redbiotec AG
  • ASSET PURCHASE
  • APR 12, 2018: HELSINN PROVIDES GRANT FOR ESMO'S PRECEPTORSHIP PROGRAMME FOR SUPPORTIVE AND PALLIATIVE CARE

Note: Deals include all announced pharmaceuticals & healthcare deals from 2012 onwards, GlobalData Helsinn Healthcare SA, Deals By Therapy Area, 2012 to YTD 2018 Therapy Area Oncology Central Nervous System Dermatology Gastrointestinal Genito Urinary System And Sex Hormones Mus

  • Healthcare
  • Therapy
  • Switzerland
  • Company
  • Helsinn Group

GlobalData Region Europe North America Asia-Pacific Middle East and Africa South and Central America No. of Deals ## ## NA NA NA Deal Value (US$ million) NA NA NA NA NA HUMABS BIOMED SA, PHARMACEUTICALS & HEALTHCARE, DEALS BY THERAPY AREA, 2012 TO YTD 2018 HUMABS BIOMED SA, PHARM

  • Pharmaceutical
  • Therapy
  • Switzerland
  • Deals & Alliance
  • Humabs BioMed SA
  • Biotie Therapies Corp. capital raising volume and value trend (2012-YTD2016)
  • OF CONTENTS

Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement Biotie Therapies Corp.

  • Pharmaceutical
  • Therapy
  • Switzerland
  • Corporate Finance
  • Biotie Therapies Corp.
  • PARTNERSHIPS

GlobalData Sensile Medical AG, reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Therapy
  • Switzerland
  • Company
  • Deals & Alliance
  • Sensile Medical AG
  • Jan 10, 2017: Debiopharm International Announces positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI patients
  • EXPERIMENTAL THERAPEUTICS AND DEBIOPHARM ENTER INTO AGREEMENT TO DEVELOP EPIGENETIC ONCOLOGY TARGET

Almac Discovery' s pipeline products include ALM##, a microtubule binding agent in Phase ## for the treatment of solid tumours; ALM##, a allosteric Akt inhibitor; and Wee-## Inhibitor for the control of cell cycle.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Switzerland
  • Debiopharm Group

Profiling all major companies, industries and geographies, MarketLine is one of the most prolific publishers of business information today.

  • Neurology
  • Pharmaceutical
  • Therapy
  • Switzerland
  • Dana-Farber Cancer Institute, Inc.